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Contrast-Enhanced Whole-Heart Coronary
Magnetic Resonance Angiography at 3.0-T
A Comparative Study With X-Ray Angiography in a Single Center
Qi Yang, MD,* Kuncheng Li, MD, PHD,* Xin Liu, MD,† Xiaoming Bi, PHD,‡ Zhi Liu, MD,*
Jing An, MS,§ Al Zhang, PHD,§ Renate Jerecic, PHD, Debiao Li, PHD†
Beijing, Shenzhen, and Shanghai, China; and Chicago, Illinois
Objectives The purpose of this study was to prospectively evaluate the diagnostic performance of 3.0-T contrast-enhanced whole-
heart coronary magnetic resonance angiography (CMRA) in patients with suspected coronary artery disease (CAD).
Background A slow-infusion, contrast-enhanced whole-heart CMRA approach has recently been developed at 3.0-T. The accu-
racy of this technique has not yet been determined among patients with suspected CAD.
Methods The 3.0-T contrast-enhanced whole-heart CMRA was performed in 69 consecutive patients. An electrocardiography-
triggered, navigator-gated, inversion-recovery prepared, segmented gradient-echo sequence was used to acquire iso-
tropic whole-heart CMRA with slow infusion of 0.2 mmol/kg gadobenate dimeglumine. The diagnostic accuracy of
whole-heart CMRA in detecting significant stenoses (50%) was evaluated using X-ray angiography as the reference.
Results The CMRA examinations were successfully completed in 62 patients. Acquisition time of whole-heart CMRA proce-
dure was 9.0  1.9 min. The 3.0-T whole-heart CMRA correctly identified significant CAD in 32 patients and correctly
ruled out CAD in 23 patients. The sensitivity, specificity, and accuracy of whole-heart CMRA for detecting significant
stenoses were 91.6% (87 of 95), 83.1% (570 of 686), and 84.1% (657 of 781), respectively, on a per-segment basis.
These values were 94.1% (32 of 34), 82.1% (23 of 28), and 88.7% (55 of 62), respectively, on a per-patient basis.
Conclusions Contrast-enhanced whole-heart CMRA with 3.0-T allows for the accurate detection of coronary artery stenosis
with high sensitivity and moderate specificity. (J Am Coll Cardiol 2009;54:69–76) © 2009 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.03.016m
v
g
C
p
1
i
c
H
S
t
t
l
r
N
pubstantial progress has been made in coronary magnetic
esonance angiography (CMRA) since the first reports of
isualizing the ostia of coronary arteries in the late 1980s
1,2). A prospective multicenter study shows that
-dimensional CMRA using a spoiled gradient-echo se-
uence allows for accurate detection of coronary artery
isease (CAD) in the proximal and middle segments of
oronary arteries at 1.5-T (3). Steady-state free precession
SSFP) imaging (4) was later shown to offer superior
ignal-to-noise ratio (SNR) and blood-myocardium con-
rast in CMRA. In recent years, improved gradient perfor-
rom the *Department of Radiology, Xuanwu Hospital, Capital Medical University,
eijing, China; †Department of Radiology, Northwestern University, Chicago,
llinois; ‡Siemens Medical Solutions USA, Inc., Chicago, Illinois; §Siemens Mindit
agnetic Resonance Ltd., Shenzhen, China; and Siemens Ltd. China, Healthcare
agnetic Resonance, Shanghai, China. Dr. Kuncheng Li has received lecture fees
nd/or grant support from Siemens Medical Solutions and Bracco Diagnostics
maging. Dr. Debiao Li has received research support from Siemens Medical
olutions and Bracco Diagnostics. Dr. Bi, Mrs. An, Dr. Zhang, and Dr. Jerecic are
mployees of Siemens.f
Manuscript received December 18, 2008; revised manuscript received February 17,
009, accepted March 10, 2009.ance and radiofrequency (RF) receiving coils and ad-
anced data acquisition techniques, including navigator
ating and parallel imaging (5,6), allowed whole-heart
See page 77
MRA within 10 to 15 min (7). A recent study of 131
atients using the SSFP whole-heart CMRA approach at
.5-T demonstrates moderate sensitivity and high specific-
ty for noninvasive detection of significant narrowing in
oronary arterial segments of 2 mm in diameter (8,9).
owever, a comparative study is required to verify whether
SFP improves the diagnostic accuracy over the conven-
ional gradient-echo sequence.
Despite the substantial progress in imaging hardware and
echniques, to date the clinical utilization of CMRA remains
imited for the detection of CAD. Relatively low spatial
esolution and long imaging time are the 2 major factors.
ow, 3.0-T has been shown to be a promising platform for
erforming CMRA (10). The theoretical doubling of SNR
rom 1.5- to 3.0-T can be traded for improved spatial
C
c
t
3
p
M
S
9
a
E
e
a
g
t
m
a
w
r
c
d
e
I
o
P
2

t
C
w
T
E
m
A
w
p
d
a
t
f
70 Yang et al. JACC Vol. 54, No. 1, 2009
3.0-T Contrast-Enhanced Whole-Heart CMRA June 30, 2009:69–76resolution and/or reduced imag-
ing time. Nevertheless, the SSFP
imaging technique that has gained
wide acceptance at 1.5-T is prone
to imaging artifacts at 3.0-T be-
cause of the increased magnetic
field inhomogeneity and RF dis-
tortion at higher field strengths. In
addition, energy deposition is in-
creased by a factor of 4 from 1.5-
to 3.0-T.
A recent study has demon-
strated the feasibility of whole-
heart CMRA at 3.0-T with slow
infusion of a high relaxivity clin-
ical contrast media Gd-BOPTA
(11), using a spoiled gradient-
echo technique. Spoiled gradient-
echo imaging is less sensitive to
static and RF field inhomogene-
ities, and reduces RF power depo-
sition and repetition time (TR) as
compared with SSFP imaging.
ontrast-enhanced data acquisition improves SNR and
ontrast-to-noise ratio (CNR). The purpose of this study was
o prospectively evaluate the diagnostic performance of this
.0-T whole-heart CMRA technique on patients with sus-
ected CAD.
ethods
tudy population. From April 2007 to July 2008, a total of
6 consecutive patients scheduled for conventional coronary
Abbreviations
and Acronyms
CAD  coronary artery
disease
CMRA  coronary
magnetic resonance
angiography
CNR  contrast-to-noise
ratio
ECG  electrocardiography
FLASH  fast low-angle
shot
QCA  quantitative
coronary angiography
RCA  right coronary
artery
RF  radiofrequency
SNR  signal-to-noise ratio
SSFP  steady-state free
precession
TR  repetition time
Figure 1 Flow Chart of Patient Inclusion
CAD  coronary artery disease; CMRA  coronary magnetic resonance angiographngiography were prospectively recruited in this study.
xclusion criteria were general contraindications to MR
xamination (claustrophobia, pacemaker), unstable angina,
trial fibrillation, patients with coronary stents or bypass
rafts, and renal insufficiency (estimated glomerular filtra-
ion rate assessed by creatinine clearance 60 ml/min/1.73
2). Twenty-seven patients were excluded for these reasons,
nd 69 patients (36 men; age 61  10 years) underwent
hole-heart CMRA before conventional coronary angiog-
aphy (Fig. 1). The average interval between CMRA and
ardiac catheterization was 2 days, ranging from 0 to 12
ays. No clinical cardiac events were reported between the
xaminations. The study protocol was approved by the
nstitutional Review Board. Written informed consent was
btained from each patient.
atient preparation. A beta-blocker (metoprolol tartrate,
5 to 50 mg) was given orally to patients with heart rate
75 beats/min before CMRA. No nitroglycerin was given
o the patients before the test.
ontrast-enhanced whole-heart CMRA. The CMRA
as performed on a 3.0-T whole-body scanner (MAGNE-
OM Trio, A Tim System, Siemens AG Healthcare,
rlangen, Germany) with maximum slew rate of 200
T/m/ms and a maximum gradient strength of 40 mT/m.
12-element matrix coil (6 anterior and 6 posterior elements)
as activated for data collection. Patients were trained to
erform regular, shallow breathing and to avoid changes in
epth of breathing during the data acquisition. The R-wave
cquired from a 3-lead wireless vectorcardiogram was used to
rigger the data acquisition. All images were collected under
ree breathing with the patient in supine position.
 electrocardiography; GFR  glomerular filtration rate.y; ECG
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June 30, 2009:69–76 3.0-T Contrast-Enhanced Whole-Heart CMRAThe procedures were as follows: 2-dimensional scout
mages were first obtained in 3 orthogonal orientations to
dentify the position of the heart and diaphragm. To
etermine the optimal data acquisition window, retrospec-
ive electrocardiography (ECG)-triggered cine images (50
ardiac phases reconstructed) were acquired in a 4-chamber
iew using a fast low-angle shot (FLASH) sequence during
ree breathing. The global cardiac motion was visually
ssessed from cine images to determine the patient-specific
rigger-delay time and duration of data acquisition window
er heartbeat. For whole-heart CMRA, 0.2 mmol/kg body
eight of Gadobenate dimeglumine (MultiHance, Bracco
maging SpA, Milan, Italy) was slowly infused using a
ower injector (Spectris, Medrad, Indianola, Pennsylvania)
t a rate of 0.3 ml/s, immediately followed by 20 ml saline
t the same rate. Sixty seconds after the initiation of contrast
dministration, whole-heart CMRA data acquisition was
tarted. The imaging volume was prescribed in the axial
lane to cover the entire heart. A navigator-gated, ECG-
riggered, fat-saturated, inversion-recovery prepared seg-
ented 3-dimensional FLASH sequence was employed
11). Prospective real-time adaptive motion correction was
pplied in the superior-inferior direction to compensate for
he respiratory motion with a correction factor of 0.6 (12).
maging parameters included the following: TR/TE (echo
ime)  3.0/1.4 ms, flip angle  20°, readout bandwidth 
10 Hz/pixel, acquired voxel size  1.3  1.3  1.3 mm3
nd interpolated to 0.65  0.65  0.65 mm3. Data
cquisition was accelerated by employing generalized auto-
alibrating partially parallel acquisitions in the phase-
ncoding direction with a factor of 2. A nonselective
nversion pulse was applied before the navigator-gating and
ata acquisition to suppress background tissues. The
nversion-recovery time was 200 ms.
onventional coronary angiography. X-ray coronary an-
iography was performed in all patients and evaluated by
uantitative coronary angiography (QCA [QuantCor
CA, Siemens AG Healthcare]) by 2 cardiologists in
onsensus who were blinded to the CMRA results. The
tandard 15-segment American Heart Association classifi-
ation system was used. All coronary artery stenoses were
raded in at least 2 orthogonal views, and the measurement
as performed in the projection that showed the highest
egree of stenoses. Stenoses were quantitatively evaluated
or segments with a reference diameter of 1.5 mm or more.
egments distal to complete occlusions were excluded for
nalysis. Significant CAD was defined as a luminal diameter
eduction of 50% in coronary arteries.
MRA image analysis. All CMRA images were trans-
erred to an external workstation (MMWP, Siemens AG
ealthcare), and patient information was removed. All
MRA images were independently assessed by 2 experi-
nced readers who were blinded to the patient information.
xial source images, curved multiplanar reformations, and
hin-slab maximum intensity projection images were as-
essed on a per-segment basis. CoronaViz software (Sie- Cens Corporate Research, Princeton, New Jersey) were
sed for CMRA images to project multiple vessels onto a
ingle image. The MR image quality was graded on a
-point scale: 1  nonassessable with severe image artifacts,
oor vessel contrast; 2  assessable with moderate image
rtifacts, fair vessel contrast; 3  assessable with minor
rtifacts, good vessel contrast; and 4  assessable with no
pparent artifacts, excellent vessel contrast) (3). The severity
f luminal diameter reduction as being 50% or 50% was
isually assessed by 2 readers independently. The disagree-
ent of diagnosis between the 2 readers was settled by a
onsensus reading.
tatistical analysis. All statistical analysis was performed
sing statistical software (version 9.1, SAS Institute Inc.,
ary, North Carolina). Quantitative variables were ex-
ressed as mean value  SD, and categorical variables as
ercentages. The diagnostic performance of CMRA for the
etection of significant coronary artery stenosis (sensitivity,
pecificity, positive predictive value, negative predictive
alue, and accuracy with 95% confidence intervals) were
alculated on a per-segment, -vessel, and -patient basis
sing invasive X-ray coronary angiography as the reference
tandard. In the primary analysis, only the assessable seg-
ents were included; and the calculations were performed
n per-patient, -vessel, and -segment basis. In the second
nalysis, the intention-to-diagnose approach (13) was used,
nd nonassessable segments were considered to have a
tenosis (14). Interobserver agreement was assessed on a
egmental basis for the image quality grading and stenosis
nalysis by using a weighted and unweighted kappa,
espectively.
esults
he characteristics of the study population are summarized
n Table 1. The CMRA was successfully completed in 62 of
9 (90%) patients. Seven patient studies were aborted owing
o poor ECG signal (n  3), or extremely low respiratory
ating efficiency (navigator efficiency 20% by the time
ne-half of the imaging data were collected; n  4).
cquisition time of whole-heart CMRA was 9.0 1.9 min.
ean heart rate during CMRA was 67  7 beats/min. The
MRA was acquired during diastole in 53 patients (acqui-
ition window 135 33 ms) and during systole in 9 patients
acquisition window 89  8 ms). The trigger-delay time
as 554  143 ms. The average navigator efficiency was
5%. The average duration of contrast injection was 1.5
in. Twenty (29%) patients received an oral beta-blocker
efore CMRA. Figure 2 shows representative CMRA
mages from a patient with normal coronary arteries.
mage quality of the whole-heart CMRA. The CMRA
mage quality of 62 patients is summarized in Table 2.
inety-three of 781 (12%) segments with a reference
uminal diameter 1.5 mm on QCA were evaluated as
onassessable. The reasons for these segments were poor
NR (n  27), motion artifacts (n  39), and small
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3.0-T Contrast-Enhanced Whole-Heart CMRA June 30, 2009:69–76iameter (n  27). Most segments were assessable in the left
ain coronary artery (98%, 61 of 62), followed by right
oronary artery (RCA [90%, 260 of 288]) and left anterior
escending coronary artery (89%, 220 of 246), and the
east in the left circumflex coronary artery (80%, 147 of
85). The image score was 2.8  1.0. The weighted
appa value for interobserver agreement for image quality
rading was 0.82.
iagnostic performance of CMRA compared with
CA. The 3.0-T contrast-enhanced CMRA correctly
dentified significant CAD (presence of at least 1 steno-
Characteristics of the Study Population
Table 1 Characteristics of the Study Popula
Characteristics
Age, yrs
Range
Sex, male/female
Mean heart rate during CMRA, beats/
min
Range
Body mass index, kg/m2
Hypertension
Hypercholesterolemia
Diabetes mellitus
Current or prior cigarette smoking
Chest pain
Prior myocardial infarction
Stenosis on X-ray coronary angiography
1-vessel
2-vessel
3-vessel
4-vessel
Values are n (%) or mean  SD.
CMRA  coronary magnetic resonance angiography.
Figure 2 3.0-T Contrast-Enhanced Whole-Heart CMRA Images o
Contrast-enhanced whole-heart cardiac magnetic resonance angiography (CMRA) im
image provides an overview of coronary anatomy and clearly depicts the right coro
D2). (B) Curved multiplanar reformation image using CoronaViz software shows this) in 32 of 34 patients (sensitivity 94.1%) and correctly
uled out CAD in 23 of 28 patients (specificity 82.1%).
MRA failed to detect CAD in 2 patients (2 missed
ingle-vessel disease, 1 in the first diagonal branch and 1
n the distal RCA). In 3 patients, CMRA detected CAD
espite normal QCA (2 distal left circumflex coronary
rtery, 1 posterior descending artery, 1 distal left anterior
escending coronary artery). Two patients who had no
ignificant CAD on QCA were regarded as false posi-
ives because nonassessable segments were included for
nalysis.
Patients Who
derwent CMRA
(n  69)
Patients With
Successful CMRA
(n  62)
61 10 61 11
38–82 38–82
36/33 30/32
67 6 67 7
52–83 52–83
24.2 2.8 24.1 2.8
31 (45%) 29 (47%)
37 (54%) 34 (55%)
19 (28%) 19 (31%)
27 (39%) 24 (39%)
45 (65%) 40 (65%)
11 (16%) 9 (15%)
38 (55%) 34 (55%)
11 10
18 16
5 4
4 4
-Year-Old Woman With Normal Coronary Arteries
of a 71-year-old woman with normal coronary arteries. (A) Volume-rendered
rtery (RCA), left anterior descending artery (LAD), and diagonal branches (D1,
ain artery (LM), LAD, left circumflex artery (LCX), and RCA.tion
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June 30, 2009:69–76 3.0-T Contrast-Enhanced Whole-Heart CMRAIn a total of 688 assessable coronary segments, QCA
etected a total of 91 lesions (50%). CMRA correctly
dentified 83 of these lesions (sensitivity 91.2%). In 570
egments, stenosis was ruled out correctly by CMRA
specificity 95.5%). The main reasons for false positives
ere poor opacification and motion artifacts (89%). For
he intention-to-diagnose analysis, the specificity de-
reased to 83.1% (570 of 686). A detailed overview of the
iagnostic performance of 3.0-T CMRA compared with
CA is summarized in Table 3. Figures 3 and 4 illustrate
he detection of significant stenoses by CMRA with
orrelation to QCA. The kappa value for interobserver
greement for coronary artery stenosis detection with
MRA was 0.84.
mage Quality of 62 Patients With Successful CMRA
Table 2 Image Quality of 62 Patients With Successful CMRA
Artery
No. of Segments
>1.5 mm on QCA
No. of Assessable
Segments on CMRA
LM 62 61 (98%)
LAD
Proximal 62 61 (98%)
Middle 60 58 (97%)
Distal 57 51 (90%)
Diagonal branches 67 50 (75%)
LCX
Proximal 62 60 (97%)
Distal 50 41 (82%)
Marginal branches 73 46 (63%)
RCA
Proximal 62 61 (98%)
Middle 61 60 (98%)
Distal 58 54 (93%)
PDA/PL 107 85 (79%)
Total 781 688 (88%)
MRA coronary magnetic resonance angiography; LAD left anterior descending coronary arter
rtery/posterolateral branch; QCA  quantitative coronary angiography; RCA  right coronary art
Diagnostic Performance of 3.0-T Contrast-Enhan
Table 3 Diagnostic Performance of 3.0-T Co
Per Patient
All segments (n  62)
Accuracy 88.7 (55/62) [78.1–95.3]
Sensitivity 94.1 (32/34) [80.3–99.3]
Specificity 82.1 (23/28) [63.1–93.9]
PPV 86.5 (32/37) [71.2–95.5]
NPV 92.0 (23/25) [74.0–99.0]
Assessable segments (n  60)
Accuracy 91.7 (55/60) [81.6–97.2]
Sensitivity 94.1 (32/34) [80.3–99.3]
Specificity 88.5 (23/26) [69.9–97.6]
PPV 91.4 (32/35) [76.9–98.2]
NPV 92.0 (23/25) [74.0–99.0]Data are % (raw data) [95% confidence interval].
CMRA  coronary magnetic resonance angiography; NPV  negative prediscussion
n this work, we have prospectively examined the diagnostic
alue of contrast-enhanced whole-heart CMRA at 3.0-T on
atients suspected of CAD. Using an inversion recovery-
repared, navigator-gated spoiled gradient-echo sequence,
MRA was able to depict significant stenoses with overall
ensitivity of 91.6%, 92.9%, and 94.1% based on per-
egment, -vessel, and -patient analyses, respectively. The
egative predictive values were 98.6%, 96.9%, and 92.0%,
espectively, indicating that the technique can reliably rule
ut significant stenoses, consistent with findings from pre-
ious studies (8,9). By including all false-positive nonassess-
ble segments, the positive predictive values were lower
42.9%, 76.5%, and 86.5%, respectively); however, they still
Causes of Nonassessability
Image Quality
of CMRA
Poor
Opacification
Motion
Artifacts
Small
Caliber
0 1 0 3.3 0.7
0
0 1 0 3.2 0.7
1 1 0 3.1 0.7
3 1 2 2.8 1.1
6 4 7 2.6 0.9
0 2 0 2.8 0.8
2 4 3 2.4 1.1
6 13 8 2.1 1.0
0 1 0 3.3 0.7
0 1 0 3.2 0.8
2 2 0 2.7 1.1
7 8 7 2.3 1.1
27 39 27 2.8 1.0
 left circumflex coronary artery; LM left main coronary artery; PDA/PL posterior descending
Whole-Heart CMRA
t-Enhanced Whole-Heart CMRA
Per Vessel Per Segment
(n  248) (n  781)
(223/248) [85.5–93.4] 84.1 (657/781) [81.4–86.6]
(65/70) [84.1–97.6] 91.6 (87/95) [84.1–96.3]
(158/178) [83.2–93.0] 83.1 (570/686) [80.1–85.8]
(65/85) [66.0–85.0] 42.9 (87/203) [36.0–50.0]
(158/163) [93.0–99.0] 98.6 (570/578) [97.3–99.4]
(n  234) (n  688)
(219/234) [89.7–96.4] 94.9 (653/688) [93.0–96.4]
(61/66) [83.2–97.5] 91.2 (83/91) [83.4–96.1]
(158/168) [89.3–97.1] 95.5 (570/597) [93.5–97.0]
(61/71) [75.6–93.0] 75.5 (83/110) [66.3–83.2]
(158/163) [93.0–99.0] 98.6 (570/578) [97.3–99.4]ced
ntras
89.9
92.9
88.8
76.5
96.9
93.6
92.4
94.1
85.9
96.9ictive value; PPV  positive predictive value.
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3.0-T Contrast-Enhanced Whole-Heart CMRA June 30, 2009:69–76epresent an improvement over a recent study using the
SFP technique at 1.5-T (14%, 38%, and 50%, respectively)
14). The reduced incidents of false positives could be
ttributed to the potential benefits of contrast-enhanced
ata acquisition, which is T1-weighted, does not depend on
lood inflow, and is less prone to signal loss due to complex
ow as compared with SSFP data acquisition.
Previous studies using whole-heart CMRA at 1.5-T have
emonstrated promising clinical results, particularly for high
egative predictive value. However, long scan time and
elatively low spatial resolution have prevented its wide
linical acceptance as a routine test for coronary artery
tenosis detection. The 3.0-T systems have the potential to
mprove SNR by a factor of 2 as compared with 1.5-T with
he same imaging sequence.
Although SSFP has been the sequence of choice for
MRA at 1.5-T, there are substantial technical challenges
f using SSFP imaging for CMRA at 3.0-T because of
ncreased B0 and B1 field inhomogeneities and power
eposition, despite various improvements in recent years
15–17). Contrast-enhanced data acquisition overcomes
any problems associated with SSFP and allows faster
maging because of its shorter TR. Reduced imaging time is
ritically important for whole-heart CMRA as long scan
imes tend to cause lower image quality from increased
otion artifacts and reduced coronary SNR. The 3.0-T
maging and contrast-enhancement combined with inversion-
ecovery preparation allow high contrast between blood and
ackground tissue. The depiction of distal coronary artery
egments can be improved as a result. In this study, we were
ble to assess coronary artery segments with diameters
1.5 mm, as compared with 2.0 mm in previous 1.5-T
Figure 3 3.0-T Contrast-Enhanced Whole-Heart CMRA Images o
3.0-T contrast-enhanced whole-heart CMRA images of a 54-year-old female pat
sis in the middle RCA (arrow), with good correlation with X-ray angiography (ar
CMRA images. Abbreviations as in Figure 2.tudies (9). rMultislice computed tomography emerged as a noninva-
ive method for imaging the coronary arteries several years
go. However, it has the disadvantages of requiring rapid
njection of iodinated contrast medium and of exposing
atients to ionizing radiation. In addition, blooming artifact
rom calcification leads to false positive diagnosis in many
ases. A recent study by Liu et al. (18) demonstrated that
MRA has advantages over computed tomography angiog-
aphy in the depiction of coronary lumen with severe
alcification.
A major challenge for CMRA remains respiration-
nduced motion artifacts. Adaptive navigator-gating and
otion correction is an effective method for reducing
espiratory motion artifacts. However, the effectiveness of
he method is related to the patient’s breathing pattern.
atient training and practice before data acquisition for
aintaining regular breathing should be useful to improve
he gating efficiency and image quality of CMRA.
tudy limitations. Several important limitations exist in
he current study. First, a fixed delay time of 60 s was
pplied between initiation of contrast agent infusion and
tart of imaging data acquisition. Such a setting may not
ecessarily be optimal for every patient owing to variations
n physiological conditions (e.g., cardiac output, heart rate,
lood pressure, respiratory gating efficiency) and contrast
inetics. Automatic triggering of data acquisition based on
eal-time tracking of signal enhancement (19) tailors such
elay time to individual subjects and may potentially opti-
ize signal enhancement for each patient. Second, com-
ared with competing techniques, including X-ray angiog-
aphy and computed tomography coronary angiography, the
maging time for CMRA is still long and the spatial
-Year-Old Woman With Coronary Artery Stenosis
aximum intensity projection image (A) of CMRA detects a significant steno-
B). Both readers interpreted this as significant stenosis on the basis off 54
ient. M
row) (esolution is relatively low. Combined with dedicated 32-
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June 30, 2009:69–76 3.0-T Contrast-Enhanced Whole-Heart CMRAhannel or even 128-channel phased-array coils, 2-dimensional
arallel imaging with higher acceleration factors should allow
urther improvement in imaging speed and/or spatial resolu-
ion (17,20). Third, 3.0-T imaging relies on slow injection of
Figure 4 3.0-T Contrast-Enhanced Whole-Heart CMRA Images o
(A, B) Contrast-enhanced whole-heart CMRA maximum intensity projection images
middle RCA (arrows), respectively. (C, D) The volume-rendered images (Syngo InS
RCA (arrows), which were consistent (E, F) with the findings (arrows) of conventio
tions as in Figure 2.ontrast media. Coronary veins are also enhanced as a result, ihich may impair the depiction of coronary arteries. Fourth,
se of contrast media results in additional study cost as well as
otential side effects, particularly for patients with impaired
enal function. It is also difficult to repeat the scan in the same
5-Year-Old Man With Atypical Chest Pain
a significant stenosis in the proximal LCX and a nonsignificant stenosis in the
Siemens AG Healthcare, Erlangen, Germany) have the same findings in LCX and
ronary angiography. AO  aorta; OM  obtuse marginal artery; other abbrevia-f a 7
show
pace,
nal comaging session if the acquisition is aborted for some reason.
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3.0-T Contrast-Enhanced Whole-Heart CMRA June 30, 2009:69–76urther development of noncontrast (21) or reduced dose (22)
MRA techniques will alleviate these problems.
onclusions
hole-heart CMRA at 3.0-T with slow infusion of con-
rast agent allows for noninvasive detection of significant
oronary artery stenosis with high sensitivity and moderate
pecificity. Improved SNR and CNR from high field
trength and contrast enhancement warrant further devel-
pment of CMRA to allow for whole-heart coverage with
igher spatial resolution and/or shorter imaging time. Fi-
ally, it is possible to integrate first-pass perfusion, CMRA,
nd delayed enhancement in the same imaging session at
.0-T for a comprehensive examination.
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